309 related articles for article (PubMed ID: 27267714)
1. Endometrial Cancer-Associated FGF18 Expression Is Reduced by Bazedoxifene in Human Endometrial Stromal Cells In Vitro and in Murine Endometrium.
Flannery CA; Fleming AG; Choe GH; Naqvi H; Zhang M; Sharma A; Taylor HS
Endocrinology; 2016 Oct; 157(10):3699-3708. PubMed ID: 27267714
[TBL] [Abstract][Full Text] [Related]
2. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.
Buell-Gutbrod R; Cavallo A; Lee N; Montag A; Gwin K
Int J Gynecol Pathol; 2015 Jan; 34(1):65-73. PubMed ID: 25473755
[TBL] [Abstract][Full Text] [Related]
3. Endometrial effects of a tissue selective estrogen complex containing bazedoxifene/conjugated estrogens as a menopausal therapy.
Pickar JH; Yeh IT; Bachmann G; Speroff L
Fertil Steril; 2009 Sep; 92(3):1018-1024. PubMed ID: 19635613
[TBL] [Abstract][Full Text] [Related]
4. Effects of bazedoxifene/conjugated estrogens on the endometrium and bone: a randomized trial.
Pinkerton JV; Harvey JA; Lindsay R; Pan K; Chines AA; Mirkin S; Archer DF;
J Clin Endocrinol Metab; 2014 Feb; 99(2):E189-98. PubMed ID: 24438370
[TBL] [Abstract][Full Text] [Related]
5. Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide.
Palacios S; Currie H; Mikkola TS; Dragon E
Maturitas; 2015 Apr; 80(4):435-40. PubMed ID: 25684082
[TBL] [Abstract][Full Text] [Related]
6. Tissue-selective estrogen complexes for postmenopausal women.
Mirkin S; Komm BS
Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
[TBL] [Abstract][Full Text] [Related]
7. Selective estrogen modulators in menopause.
Gambacciani M
Minerva Ginecol; 2013 Dec; 65(6):621-30. PubMed ID: 24346250
[TBL] [Abstract][Full Text] [Related]
8. Endometrial profile of bazedoxifene acetate alone and in combination with conjugated equine estrogens in a primate model.
Ethun KF; Wood CE; Cline JM; Register TC; Appt SE; Clarkson TB
Menopause; 2013 Jul; 20(7):777-84. PubMed ID: 23793168
[TBL] [Abstract][Full Text] [Related]
9. Development of conjugated estrogens/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone loss.
Komm BS; Mirkin S; Jenkins SN
Steroids; 2014 Nov; 90():71-81. PubMed ID: 24929044
[TBL] [Abstract][Full Text] [Related]
10. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
Parish SJ; Gillespie JA
Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the safety of long-term bazedoxifene treatment on the reproductive tract in postmenopausal women with osteoporosis: results of a 7-year, randomized, placebo-controlled, phase 3 study.
Palacios S; de Villiers TJ; Nardone Fde C; Levine AB; Williams R; Hines T; Mirkin S; Chines AA;
Maturitas; 2013 Sep; 76(1):81-7. PubMed ID: 23871271
[TBL] [Abstract][Full Text] [Related]
12. Comparative safety of conjugated estrogens/bazedoxifene versus estrogen/progestin combination hormone therapy among women in the United States: a multidatabase cohort study.
Hoffman SR; Governor S; Daniels K; Seals RM; Ziyadeh NJ; Wang FT; Dai D; Mcmahill-Walraven CN; Shuminski P; Frajzyngier V; Zhou X; Shen R; Garg RK; Fournakis N; Lanes S; Beachler DC
Menopause; 2023 Aug; 30(8):824-830. PubMed ID: 37449720
[TBL] [Abstract][Full Text] [Related]
13. [Third generation selective estrogen receptor modulators: benefits beyond bone. II, endometrial action].
Calaf Alsina J; Coronado MartÃn PJ
Med Clin (Barc); 2013 Mar; 140(6):266-71. PubMed ID: 23276611
[TBL] [Abstract][Full Text] [Related]
14. Tissue-selective agents: selective estrogen receptor modulators and the tissue-selective estrogen complex.
Pickar JH; Mirkin S
Menopause Int; 2010 Sep; 16(3):121-8. PubMed ID: 20956688
[TBL] [Abstract][Full Text] [Related]
15. Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women.
Mirkin S; Komm BS; Pan K; Chines AA
Climacteric; 2013 Jun; 16(3):338-46. PubMed ID: 23038989
[TBL] [Abstract][Full Text] [Related]
16. Treatment with bazedoxifene and conjugated estrogens results in regression of endometriosis in a murine model.
Naqvi H; Sakr S; Presti T; Krikun G; Komm B; Taylor HS
Biol Reprod; 2014 Jun; 90(6):121. PubMed ID: 24740602
[TBL] [Abstract][Full Text] [Related]
17. Progestin-induced heart and neural crest derivatives-expressed transcript 2 inhibits angiopoietin 2 via fibroblast growth factor 9 in human endometrial stromal cells.
Murata H; Tsuzuki T; Kido T; Kakita-Kobayashi M; Kida N; Hisamatsu Y; Okada H
Reprod Biol; 2019 Mar; 19(1):14-21. PubMed ID: 30852242
[TBL] [Abstract][Full Text] [Related]
18. Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes.
Smith CL; Santen RJ; Komm B; Mirkin S
Breast Cancer Res; 2014 Jun; 16(3):212. PubMed ID: 25928299
[TBL] [Abstract][Full Text] [Related]
19. Treating menopausal symptoms with a tissue-selective estrogen complex.
Levine JP
Gend Med; 2011 Apr; 8(2):57-68. PubMed ID: 21536225
[TBL] [Abstract][Full Text] [Related]
20. Conjugated estrogen/bazedoxifene tablets for the treatment of moderate-to-severe vasomotor symptoms associated with menopause.
Mirkin S; Komm B; Pickar JH
Womens Health (Lond); 2014 Mar; 10(2):135-46. PubMed ID: 24601804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]